ICER Faces New Foe As Patient, Disability Alliance Takes Aims At Reports On Mayzent, Spravato


An article in The Pink Sheet highlighted the Partnership to Improve Patient Care (PIPC)’s involvement with Value Our Health — a new initiative supported by organizations representations patients and people with disabilities. The article highlights Value Our Health’s opposition to the Institute for Clinical and Economic Review’s (ICER) use of the quality-adjusted-life-years (QALY) metric, nothing that the patients groups have long criticized the method as a one-size-fits-all approach to addressing the needs of patients. “It is disappointing that ICER…

Patient Advocates Say ICER Uses Discriminatory Cost Metrics


A coalition of patient advocates, provider groups and drug makers is criticizing the Institute for Clinical and Economic Review for using a metric they say discriminates against people with disabilities and chronic illness. ICER has responded to the criticism by saying it will include alternative, less controversial metrics in its cost-effectiveness reports. The metric at issue is the Quality-Adjusted Life-Year, which is a commonly used standard internationally to determine the cost-effectiveness of medical treatments, including…